Abstract
The present study demonstrates isolation and identification of methicillin resistance Staphylococcus aureus (MRSA) strains in the samples collected from burn patients. About 106 swab samples were collected from burn patients of >40% burn injury and were subjected to isolation using nutrient agar followed by screening using Me Re Sa selective medium agar. A total of 10 isolates with identity to S. aureus were obtained and further authenticated using Polymerase Chain Reaction and matrix assisted laser desorption/ionization time of flight mass spectrometry analysis. Presence of mec A gene and the peak pattern observations suggested seven of the 10 isolates are MRSA. Thus, the present study emphasizes the process of identification of MRSA using two different bio-analytical techniques, which authenticate the presence of MRSA.
Keywords: Burn injury, Me Re Sa selective medium, S. aureus, PCR, MALDI-TOF–MS, Methicillin resistance Staphylococcusaureus
Staphylococcus aureus is a major pathogen associated with hospital and community acquired infections around the world. Before availability of antibiotics, invasive infections caused by S. aureus were often fatal [1]. However, introduction of penicillin greatly improved the prognosis for patients with severe staphylococcal infections, but after a few years of clinical use, resistance appeared owing to the production of β-lactamases [2]. Methicillin was designed to have resistance towards β-lactamase, but methicillin resistant S. aureus (MRSA) strains that were resistant to β-lactam antibiotics was identified soon after methicillin introduced into clinical practice [3] and which was predominant in hospital acquired infections and community-acquired infections as well [4].
In clinical practice infection was a major drawback and infection related mortality was encountered in burn patients. Thus, measures to prevent and treat infections were essential for the survival of patients with extensive burns [5]. In order to avoid mortality in burn patients, accuracy and promptness in detection of MRSA for suitable antibiotic therapy for patients infected with these strains was of high demand [6].
The major problem associated with MRSA infection lies in identification of strains. The delay in process of identification worsens the situation [7]. With reference to the detection of methicillin resistance in S. aureus, several methods including classic methods of determining minimum inhibitory concentrations (MIC), screening techniques with solid culture medium containing oxacillin or cefoxitin [8], methods that detect mec A gene or its protein product (PBP 2 protein) [9] and identification using whole cell protein profiles by matrix assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF–MS) was also found advisable [10].
Thus, to facilitate, ease and to authenticate MRSA strains form samples obtained from burn patients, two different test methods were attempted, viz., PCR based nuc and mecA gene identification and MALDI-TOF–MS. In brief, present approach involves isolation of microbes from external wound sites of burn patients from various hospitals in Chennai, Tamil Nadu. Identification/differentiation and characterization of MRSA was made using regular microbial methods (phenotypic and genotypic) and also using MALDI-TOF–MS. The results were compared and authenticated.
Materials and Methods
Collection of Specimens
A total of 106 burn wound infected samples were collected using sterile swabs from external wound sites of burn patients from hospital wards, labeled properly and transported to the Microbiology laboratory of Central Leather Research Institute, Chennai within 2–3 h of collection using a cool pack and were cultured in Nutrient broth medium for 24 h at 37°C. The cultures were then serially diluted and spread on to Nutrient agar medium (Hi Media, India) and were incubated at 37°C for 24 h.
Identification and Phenotypic Study of Bacterial Strains
About one hundred and six bacterial strains of hospital origin obtained from Nutrient agar plates from the above experiment and four S. aureus type strains obtained from MTCC (Microbial Type Culture Collection, Chandigarh, India) were used for identification. S. epidermidis (MTCC 3382, MTCC 6810) was used as negative control in PCR amplification. Escherichia. coli (MTCC 521) was used as negative control for biochemical tests. The strains were identified based on growth characteristics on Barid Parker Agar Base with Egg Yolk Tellurite Emulsion (Hi Media, India), Gram staining, 3% potassium hydroxide (KOH) and catalase test [11] and spot inoculation on Mueller–Hinton agar (Hi Media, India) containing 1% of Methicillin (Sigma Chemical Co., St. Louis, Mo.) [12]. Further to identify the strains with methicillin resistance, cultures obtained were grown on Me Re Sa selective agar medium (HiMedia, India) with 1% methicillin and incubated at 37°C for 24 h. To observe the morphological features of microbes isolated, scanning electron microscopy was attempted as per procedure [13] using Jeol 840 scanning electron microscope. The isolated cultures were maintained in 10% glycerol at −20°C until further use. Further authentication of S. aureus was done using polymerase chain reaction (PCR) according to the methods summarized by Ghebremedhin et al. [14].
Preparation of Chromosomal DNA for PCR (Genotypic Identification)
Genomic DNA from the microbial cultures was prepared as reported earlier [15].
PCR for mec A and nuc Gene Detection
PCR was performed using extracted genomic DNA for simultaneous detection of nuc [16] and mecA [17] according to Merlino et al. [18]. The control organisms include S. aureus MTCC 3610, S. aureus MTCC 7443, S. epidermidis MTCC 6810 and S. epidermidis MTCC 3382. Ten μl of PCR product was analyzed by agarose gel electrophoresis [2% agarose prepared in TAE (1 mM EDTA/40 mM Tris acetate, pH 8.0)] at 50 V for 60 min. Gels were stained with ethidium bromide and were photographed under ultraviolet light. The obtained PCR product was purified and was sequenced according to the procedure described elsewhere [19].
Sample Preparation and Analysis for MALDI-TOF–MS of Intact Bacterial Cells
α-Cyano-4-hydroxycinnamic acid was dissolved in a 2:1 (H2O: ACN) solution containing 0.1% TFA for the preparation of saturated matrix [20] and the sample was prepared according to Edwards-Jones et al. [21].
Spectra were obtained using a Voyager-DE PRO Biospectrometry Workstation MALDI-TOF–MS in positive-ion mode with an acceleration voltage of 26 kV and analyzed using Powerful Voyager Version 5 Software with Data Explorer software and calibrated with Bovine serum albumin as an external standard at m/z ratio of 100–7,000 kDa. Mass spectrum was collected in positive and negative modes and each spectrum was the sum of ions obtained from 100 laser shots performed in five different regions of same well. Only peaks with intensities 0.4 mV after baseline subtraction was considered in analysis and the results were analyzed using Origin Pro statistical software version 8.0.
Antibiotic Susceptibility Tests
Disk diffusion assay was performed according to Clinical and Laboratory Standards Institute (CLSI) guidelines. Experiments were done in triplicates and the zone of inhibition was measured using antibiotic zone scale (Hi-Media, India) and antibacterial activity expressed in terms of inhibition zone (mm).
Results
The isolation and identification procedures, viz., gram-positive cocci; catalase positive; positive KOH test and growth on Barid Parker Agar Base with Egg Yolk Tellurite Emulsion without supplementation of methicillin [22], growth in methicillin spot inoculation test provided 10 microbial isolates as S. aureus (S1–S10). Further, the sequence of 3570 bases of 16s rDNA analysis of three MRSA strains (S1, S2 and S3) used for MALDI studies were 99–99.8% similar to the 16s rDNA sequences of S. aureus. Phylogenetic tree constructed showed that the isolated strains belong to S. aureus (Fig. 1a–c).
Fig. 1.
a Phylogenetic tree constructed for S. aureus based on 16s rDNA analysis (Clinical strain of MRSA S1). b Phylogenetic tree constructed for S. aureus based on 16s rDNA analysis (Clinical strain of MRSA S2). c Phylogenetic tree constructed for S. aureus based on 16s rDNA analysis (Clinical strain of MRSA S3)
Genotypic and phenotypic expression for methicillin resistance in the isolated clinical strains of S. aureus was examined using PCR. All isolates tested showed positive for nuc gene confirmed S. aureus and further the presence of mec A gene in seven isolates (S1–S7) confirmed as MRSA. Negative control strains do not contain mec A gene. The amplified mec A gene is sequenced and the phylogenetic tree (Fig. 2a–c) results showed that the gene sequence was found similar to S. aureus strain penicillin binding protein 2a (mec A) gene, using NCBI BLAST search (http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi).
Fig. 2.
a Phylogenetic tree constructed for mec A gene based on gene sequencing (Clinical strain of MRSA S1). b Phylogenetic tree constructed for mec A gene based on gene sequencing (Clinical strain of MRSA S2). c Phylogenetic tree constructed for mec A gene based on gene sequencing (Clinical strain of MRSA S3)
Followed by PCR analysis, strains confirmed as MRSA were subjected to MALDI-TOF–MS analysis for additional confirmation. Figure 3a–e illustrates MALDI-TOF–MS spectrum of clinical and reference bacterial species and most spectral peaks were observed in the representative mass range [23].
Fig. 3.
a Strain specific MALDI-TOF–MS profile of clinical isolate S1. b Strain specific MALDI-TOF–MS profile of clinical isolate S2. c Strain specific MALDI-TOF–MS profile of clinical isolate S3. d Strain specific MALDI-TOF–MS profile of clinical isolate S10. e Strain specific MALDI-TOF–MS profile of reference strain of S. aureus
Fingerprint observations of S. aureus strains studied showed three common peaks with m/z of 5514, 6013 and 6587 respectively, which were observed in all S. aureus isolates and peaks of m/z 1729, 2288, 5514, 6004, 6576 and 6885 found only in MRSA strains [21]. Presence of group peaks around 2300 in S1, S2 and S3 suggests the presence of mec element, which contributes to this group of peaks and is an agreement with previous studies [1].
Careful observation in the spectral profiles of MRSA in the present study does not provide a distinctive fingerprint (spectral profiles of S1 and S2 looks similar and S3 dis-similar) (Table 1) which suggests that the isolated MRSA strains S1 and S2 may be of same clonal origin and the strain S3 may differ in its clonal origin. Peak profile for all the isolates were summarized in Table 1. Over 90% of the peaks were reproduced in all replicates and relative intensities (but not absolute intensities) were closely comparable.
Table 1.
Summary of the mass/charge values found in Staphylococcal isolates tested
| S1 | S2 | S3 | S10 | Reference MRSA strain |
|---|---|---|---|---|
| 708 | 703 | 673 | ||
| 796 | 749 | 704 | ||
| 792 | 741 | |||
| 793 | ||||
| 1734 | 1729 | 1729 | 1731 | |
| 1835 | ||||
| 2204 | 2182 | 2195 | 2199 | |
| 2292 | 2282 | 2289 | 2285 | |
| 3451 | 3435 | 3441 | ||
| 4994 | ||||
| 5504 | 5514 | 5001 | 5057 | 5510 |
| 5031 | 5121 | |||
| 5124 | 5444 | |||
| 5514 | 5510 | |||
| 5817 | 5734 | |||
| 5817 | ||||
| 6004 | 6013 | 6013 | 6010 | 6014 |
| 6576 | 6587 | 6133 | 6140 | 6552 |
| 6885 | 6903 | 6570 | 6590 | 6898 |
| 6707 | 6703 | |||
| 6813 | 6816 | |||
| 6866 | ||||
| 7100 | 7093 |
S1 clinical isolate of MRSA1; S2 clinical isolate of MRSA2; S3 clinical isolate of MRSA3; S10 clinical isolate of MSSA10
The results of the susceptibility tests for cultures obtained from clinical samples and type strains of S. aureus against 10 antibiotics were summarized in Table 2. Antibiotic inhibition zone diameters against the strains were in compliance with CLSI guidelines.
Table 2.
Antibiogram profiles of Staphylococcus aureus (methicillin resistant) clinical isolates and MTCC strains against selected antibiotics. Disk diffusion break points are based on CLSI (Clinical Laboratory Standards Institute, formerly NCCLS) guidelines
| Microbial isolates | Am | A | C | E | G | M | Of | Ox | S | T |
|---|---|---|---|---|---|---|---|---|---|---|
| S1a | S | R | S | R | R | R | R | S | R | R |
| S2 | R | R | S | S | R | R | R | R | R | R |
| S3 | R | R | S | S | R | R | R | R | R | R |
| S4 | R | R | S | R | R | R | R | R | R | R |
| S5 | S | R | S | R | R | R | R | S | R | R |
| S6 | R | R | R | R | R | R | R | R | R | R |
| S7 | R | R | S | R | R | R | R | R | R | R |
| S8 | R | R | S | S | S | S | S | S | S | R |
| S9 | S | S | S | S | S | S | S | S | S | S |
| S10 | R | R | S | S | S | S | S | S | S | R |
| MTCCb 3610 | S | S | S | I | I | S | I | S | I | I |
| MTCC 7443 | S | S | S | I | S | S | I | S | I | I |
| MTCC 6810 | S | S | S | I | I | S | I | S | I | I |
| MTCC 3382 | S | S | S | I | I | S | I | S | I | I |
Degree of susceptibility: R resistant, I intermediate; S susceptible
Antibiotics used in this study: Am amoxicillin, 30 μg; A ampicillin, 10 μg; C chloramphenicol, 30 μg; E erythromycin, 10 μg; G gentamicin, 10 μg; M methicillin, 5 μg; Of ofloxacin, 5 μg; Ox oxacillin, 5 μg; S streptomycin, 10 μg; T tetracycline, 10 μg
aStaphylococcus aureus
bMicrobial type culture collection
Discussion
Staphylococcus aureus was a major cause of both healthcare associated and community acquired infections throughout the world [24]. Recently, emergence of MRSA despite extensive infection controls dominates and needs special attention [25]. Oxacillin has been used to replace methicillin since it was no longer the agent of choice for treatment of S. aureus infections. Detection of mec A gene by PCR was considered to be the “gold standard method” because of its simplicity and reproducibility [26]. In the present study, out of 106 isolates tested, 10 strains were found to be S. aureus based on gram staining, morphological features and 3% KOH test and growth in Me Re Sa agar supplemented with 1% methicillin and methicillin spot agar test further confirmed 7 of the 10 isolates as MRSA. From the 16s rDNA analysis and phylogenetic tree it was confirmed that the strains used in the present study belongs to S. aureus.
PCR results demonstrate 10 out of 106 isolates contain nuc gene and the presence of nuc gene was in complete agreement with the species determinations of S. aureus [27]. These strains were further tested for their methicillin resistance using PCR and seven strains had mec A gene which confirms their methicillin resistance. Results from PCR amplifications were in good agreement with growth in Me Re Sa agar supplemented with 1% methicillin and methicillin spot inoculation tests used in this study. The detection of both genes in an isolate confirms the identity of an isolate as MRSA [28]. Further, the gene sequence of purified PCR products and their phylogenetic tree confirms the identity of mec A gene.
According to Liang et al. [28] direct analysis of proteins from bacterial cell extracts by MALDI-TOF–MS has been a potential means for the identification of bacteria. Thus, in the present study the bacterial samples obtained from PCR were reconfirmed using MALDI-TOF–MS and the mass spectral data was compared with reported literature [29]. The spectral profiles of MRSA and S. aureus exhibited the difference in their mass range of 100–7000 kDa under the experimental conditions as illustrated in the Fig. 3a–e. At a finer level of discrimination, particularly in the peak pattern differences between MRSA and S. aureus isolates can be observed within m/z ranges of 1000–2500, 5000–5500, 6000–6500 kDa.
In the present study, resistance observed for MRSA strains isolated from burn wound site was on par with previous reports [30]. However, isolates S8 and S10, showed resistance against ampicillin, amoxicillin and tetracycline and this observation was supported by the previous observations [31] implying resistant S. aureus traits were most common in hospital community. Apart from these, MTCC type strains did not exhibit any resistance towards the antibiotics tested. S8 exhibits intermediate resistance to erythromycin, oflaxin, streptomycin and tetracycline. Layer et al. [31] observed a similar findings working with S. aureus strains in the hospital premises at Germany and found that most of S. aureus isolates were resistant to penicillin, ciprofloxacin, clindamycin, erythromycin and gentamicin.
Conclusion
In the present study, microbial colonies isolated from burn wound site subjected to screening for MRSA and S. aureus using standard procedures and the MRSA strains were further authenticated by their phenotypical and genotypical methods followed by MALDI-TOF analysis. We found among ten S. aureus isolates, seven isolates exhibited positive response to the said methods followed and suggests both the methods were suitable for identification of MRSA species.
Acknowledgments
One of the authors, Mr. E. Madhava Charyulu thanks Director, CLRI for providing the facilities to carry out the work and the author also thanks, Council of Scientific and Industrial Research for Financial Assistance in the form of Senior Research Fellowship and authors thank Dr.V.Jayaraman, Kilapuk Medical College for providing MRSA strains.
References
- 1.Panlilio AL, Culver DH, Gaynes RP, Banerjee S, Henderson TS, Tolson JS, Martone WJ. Methicillin-resistant Staphylococcus aureus in U.S. Hospitals, 1975–1991. Infect Contr Hosp Epidemiol. 1992;13:582–586. doi: 10.1086/646432. [DOI] [PubMed] [Google Scholar]
- 2.Kuehnert MJ, Hill HA, Kupronis BA, Tokars JI, Solomon SL, Jernigan DB. Methicillin-resistant-Staphylococcus aureus hospitalizations, United States. Emerg Infect Diseases. 2005;11:868–872. doi: 10.3201/eid1106.040831. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Cosgrove SE, Qi YL, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin-resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Contr Hosp Epidemiol. 2005;26:166–174. doi: 10.1086/502522. [DOI] [PubMed] [Google Scholar]
- 4.Abramson MA, Sexton DJ. Nosocomial methicillin-resistant and methicillin-susceptible, Staphylococcus aureus primary bacteremia: at what costs. Infect Contr Hosp Epidemiol. 1999;20:408–411. doi: 10.1086/501641. [DOI] [PubMed] [Google Scholar]
- 5.Witte W, Braulke C, Heuck D, Cuny C. Analysis of nosocomial outbreaks with multiply and methicillin-resistant Staphylococcus aureus (MRSA) in Germany: implications for hospital hygiene. Infection. 1994;22:128–134. doi: 10.1007/BF01793577. [DOI] [PubMed] [Google Scholar]
- 6.Krishnamurthy T, Ross PL. Rapid identification of bacteria by direct matrix-assisted laser desorption/ionization mass spectrometric analysis of whole cells. Rapid Commun Mass Spectrom. 1996;10:1992–1996. doi: 10.1002/(SICI)1097-0231(199612)10:15<1992::AID-RCM789>3.0.CO;2-V. [DOI] [PubMed] [Google Scholar]
- 7.Eady EA, Cove JH. Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus-an emerging problem for the management of skin and soft tissue infections. J Clin Microbiol. 2003;16:103–124. doi: 10.1097/00001432-200304000-00007. [DOI] [PubMed] [Google Scholar]
- 8.Velasco D, Tomas M, Cartelle M, Beceiro A, Perez A, Molina F, Moure R, Villanueva R, Bou G. Evaluation of different methods for detecting methicillin (oxacillin) resistance in Staphylococcus aureus. J Antimicrob Chemother. 2005;55:379–382. doi: 10.1093/jac/dki017. [DOI] [PubMed] [Google Scholar]
- 9.Cauwelier B, Gordts B, Descheemaecker P, Landuyt H. Evaluation of a disk diffusion method with cefoxitin (30 μg) for detection of methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 2004;23:389–392. doi: 10.1007/s10096-004-1130-8. [DOI] [PubMed] [Google Scholar]
- 10.Bernardo K, Pakulat N, Macht M, Krut O, Seifert H, Fleer S, Hünger F, Krönke M. Identification and discrimination of Staphylococcus aureus strains using matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Proteomics. 2002;2:747–753. doi: 10.1002/1615-9861(200206)2:6<747::AID-PROT747>3.0.CO;2-V. [DOI] [PubMed] [Google Scholar]
- 11.Gregersen T. Rapid method for distinction of Gram-negative from Gram-positive bacteria. App Microbiol Biotechnol. 1978;5:123–127. doi: 10.1007/BF00498806. [DOI] [Google Scholar]
- 12.Harbarth S, Dharan S, Liassine N, Herrault P, Auckenthaler R, Pittet D. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1999;43:1412–1416. doi: 10.1128/aac.43.6.1412. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Charyulu EM, Sekaran G, Rajakumar GS, Gnanamani A. Antimicrobial activity of secondary metabolite from marine isolate, Pseudomonas sp. against gram positive and negative bacteria including MRSA. Indian J Exp Biol. 2009;47:964–968. [PubMed] [Google Scholar]
- 14.Ghebremedhin B, Layer F, Konig W, Konig B. Genetic classification and distinguishing of staphylococcus species based on different partial gap, 16S rRNA, hsp60, rpoB, sodA, and tuf gene sequences. J Clin Microbiol. 2008;46:1019–1025. doi: 10.1128/JCM.02058-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Petinaki E, Arvaniti A, Dimitracopoulos G, Spiliopoulou I. Detection of mecA, mecR1 and mecI genes among clinical isolates of methicillin-resistant staphylococci by combined polymerase chain reactions. J Antimicrob Chemother. 2001;47:297–304. doi: 10.1093/jac/47.3.297. [DOI] [PubMed] [Google Scholar]
- 16.Brakstad OG, Aasbakk K, Maeland JA. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J Clin Microbiol. 1992;30:1654–1660. doi: 10.1128/jcm.30.7.1654-1660.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Murakami K, Minamide W, Wada K, Nakamura E, Teraoka H, Watanabe S. Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J Clin Microbiol. 1991;29:2240–2244. doi: 10.1128/jcm.29.10.2240-2244.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Merlino J, Leroi M, Bradbury R, Veal D, Harbour C. New chromogenic identification and detection of Staphylococcus aureus and methicillin-resistant S. aureus. J Clin Microbiol. 2000;38:2378–2380. doi: 10.1128/jcm.38.6.2378-2380.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Wichelhaus TA, Hunfeld KP, Boddinghaus B, Kraiczy P, Schafer V, Brade V. Rapid molecular typing of methicillin resistant Staphylococcus aureus by PCR-RFLP. Infect Control Hosp Epidemiol. 2001;22:294–298. doi: 10.1086/501903. [DOI] [PubMed] [Google Scholar]
- 20.Demirev PA, Ho YP, Ryzhov V, Fenselau C. Microorganism identification by mass spectrometry and protein database searches. Anal Chem. 1999;71:2732–2738. doi: 10.1021/ac990165u. [DOI] [PubMed] [Google Scholar]
- 21.Edwards-Jones V, Claydon MA, Evason DJ, Walker J, Fox AJ, Gordon DB. Rapid discrimination between methicillin-sensitive and methicillin-resistant Staphylococcus aureus by intact cell mass spectrometry. J Medical Microbiol. 2000;49:295–300. doi: 10.1099/0022-1317-49-3-295. [DOI] [PubMed] [Google Scholar]
- 22.Davies S, Zadik PM. Comparison of methods for the isolation of methicillin resistant Staphylococcus aureus. J Clin Pathol. 1997;50:257–258. doi: 10.1136/jcp.50.3.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Walker J, Fox AJ, Edwards-Jones V, Gordon DB. Intact cell mass spectrometry (ICMS) used to type methicillin-resistant Staphylococcus aureus: media effects and inter-laboratory reproducibility. J Microbiol Methods. 2002;48:117–126. doi: 10.1016/S0167-7012(01)00316-5. [DOI] [PubMed] [Google Scholar]
- 24.Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis. 2003;9:978–984. doi: 10.3201/eid0908.030089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA) Proc Natl Acad Sci USA. 2002;99:7687–7692. doi: 10.1073/pnas.122108599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Fluit AC, Visser MR, Schmitz FJ. Molecular detection of antimicrobial resistance. Clin Microbiol Rev. 2001;14:836–871. doi: 10.1128/CMR.14.4.836-871.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Merlino J, Watson J, Rose B, Beard-Pegler M, Gottlieb T, Bradbury R, Harbour C. Detection and expression of methicillin/oxacillin resistance in multidrug-resistant and non-multidrug-resistant Staphylococcus aureus in Central Sydney, Australia. J Antimicrob Chemother. 2002;49:793–801. doi: 10.1093/jac/dkf021. [DOI] [PubMed] [Google Scholar]
- 28.Liang X, Zheng K, Qian MG, Lubman DM. Determination of bacterial protein profiles by matrix-assisted laser desorption/ionization mass spectrometry with high-performance liquid chromatography. Rapid Commun Mass Spectrom. 1996;10:1219–1226. doi: 10.1002/(SICI)1097-0231(19960731)10:10<1219::AID-RCM660>3.0.CO;2-R. [DOI] [PubMed] [Google Scholar]
- 29.Diep BA, Chambers HF, Graber CJ, Szumowski JD, Miller LG, Han LL, Chen JH, Lin F, Lin J, Phan THV. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med. 2008;148:249–257. doi: 10.7326/0003-4819-148-4-200802190-00204. [DOI] [PubMed] [Google Scholar]
- 30.Watson J, Givney R, Beard-Pegler M, Rose B, Merlino J, Vickery A, Gottlieb T, Bradbury R, Harbour C. Comparative analysis of multidrug-resistant, non-multidrug-resistant, and archaic methicillin-resistant Staphylococcus aureus isolates from Central Sydney, Australia. J Clin Microbiol. 2003;41:867–872. doi: 10.1128/JCM.41.2.867-872.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Layer F, Ghebremedhin B, Konig W, Konig B. Heterogeneity of methicillin-susceptible Staphylococcus aureus strains at a German university hospital implicates the circulating-strain pool as a potential source of emerging methicillin-resistant S. aureus clones. Am Soc Microbiol. 2006;44:2179–2185. doi: 10.1128/JCM.02321-05. [DOI] [PMC free article] [PubMed] [Google Scholar]





